Zinc Sulfate in the Treatment of Rosacea: A Randomized, Controlled Trial
Sponsored by Essentia Health
About this trial
Last updated 15 years ago
Study ID
09-05-03
Status
Terminated
Type
Interventional
Phase
N/A
Placebo
Yes
Accepting
18+ Years
All Sexes
Trial Timing
Ended 18 years ago
What is this trial about?
Rosacea is a common chronic dermatological condition, characterized by recurrent or persistent redness, permanent dilation of small blood vessel causing small red lesions, and papules/pustules. The signs of rosacea are usually confined to the face, but may appear on the neck, scalp or trunk. Opthalmologic findings are also common. Rosacea is usually described as being most common in fair skinned women over 40. The purpose of the study is to determine whether oral Zinc Sulfate treatment is an effective treatment for facial rosacea.
What are the participation requirements?
Inclusion Criteria
* Diagnosis of facial rosacea made or confirmed by one of the investigators.
* Severity of signs of rosacea "greater than mild" at the time of enrollment.
Exclusion Criteria
* Treatment for rosacea during the 3 months prior to enrollment.
* Use of zinc dietary supplement > 25 mg per day during the 3 months prior to enrollment ( Most patients taking multivitamins with Zinc, often 15 mg per day, will not be excluded, whereas most patients taking additional Zinc supplements, often 25-50 mg per day or more will be excluded.)
* Diagnosis of rosacea fulminancy.
* Pregnant or breast feeding.